User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription

Primary tabs

download
  • Open access
  • PDF
  • -1.00 B
Van den Eynde, Benoît [UCL] Gaugler, Béatrice [UCL] Probst-Kepper, Michael [UCL] Michaux, Lucienne [UCL] Devuyst, Olivier [UCL] Lorge, Francis [UCL] Weynants, Patrick [UCL] Boon-Falleur, Thierry [UCL]

By stimulating blood lymphocytes from a renal cell carcinoma patient in vitro with the autologous tumor cells, we obtained cytolytic T lymphocyte (CTL) clones that killed several autologous and allogeneic histocompatibility leukocyte antigen (HLA)-B7 renal carcinoma cell lines. We identified the target antigen of these CTLs by screening COS cells transfected with the HLA-B7 cDNA and with a cDNA library prepared with RNA from the tumor cells. The antigenic peptide recognized by the CTLs has the sequence LPRWPPPQL and is encoded by a new gene, which we named RU2. This gene is transcribed in both directions. The antigenic peptide is not encoded by the sense transcript, RU2S, which is expressed ubiquitously. It is encoded by an antisense transcript, RU2AS, which starts from a cryptic promoter located on the reverse strand of the first intron and ends up on the reverse strand of the RU2S promoter, which contains a polyadenylation signal. This mechanism of antigen expression is unprecedented and further illustrates the notion that many peptides recognized by T cells cannot be predicted from the primary structure of the major product of the encoding gene. Antisense transcript RU2AS is expressed in a high proportion of tumors of various histological types. It is absent in most normal tissues, but is expressed in testis and kidney, and, at lower levels, in urinary bladder and liver. Short-term cultures of normal epithelial cells from the renal proximal tubule expressed significant levels of RU2AS message and were recognized by the CTLs. Therefore, this antigen is not tumor specific, but corresponds to a self-antigen with restricted tissue distribution.

  1. Van den Eynde Benoît J, van der Bruggen Pierre, T cell defined tumor antigens, 10.1016/s0952-7915(97)80050-7
  2. Guéguen, J. Immunol., 160, 6188 (1998)
  3. De Plaen E. Lurquin C. Brichard V. van der Bruggen P. Renauld J.-C. Coulie P. Szikora J.-P. Wölfel T. Van Pel A. Boon T. (1997) in The Immunology Methods Manual, Cloning of genes coding for antigens recognized by cytolytic T lymphocytes, ed Lefkovits I. (Academic Press Ltd, London), pp 692–718.
  4. De Plaen Etienne, Lurquin Christophe, Lethé Bernard, van der Bruggen Pierre, Brichard Vincent, Renauld Jean-Christophe, Coulie Pierre, Van Pel Aline, Boon Thierry, Identification of Genes Coding for Tumor Antigens Recognized by Cytolytic T Lymphocytes, 10.1006/meth.1997.0462
  5. Brouwenstijn Nathalie, Gaugler Béatrice, Krüse K. Margaretha, van der Spek Corry W., Mulder Arend, Osanto Susanne, van den Eynde Benoît J., Schrier Peter I., Renal-cell carcinoma-specific lysis by cytotoxic T-lymphocyte clones isolated from peripheral blood lymphocytes and tumor-infiltrating lymphocytes, 10.1002/(sici)1097-0215(19961009)68:2<177::aid-ijc6>3.0.co;2-v
  6. Rammensee H.-G. Bachmann J. Stevanovic S. MHC Ligands and Peptide Motifs. Molecular Biology Intelligence Unit 1997 Springer-Verlag Heidelbergpp. 462
  7. Lethé, Melanoma Res., 7, S83 (1997)
  8. Simons R W, Kleckner N, Biological Regulation by Antisense RNA in Prokaryotes, 10.1146/annurev.ge.22.120188.003031
  9. Vanhée-Brossollet Christine, Vaquero Catherine, Do natural antisense transcripts make sense in eukaryotes?, 10.1016/s0378-1119(98)00093-6
  10. Mayrand Shawn-Marie, Green William R, Non-traditionally derived CTL epitopes: exceptions that prove the rules?, 10.1016/s0167-5699(98)01342-5
  11. Guilloux Y., A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N- acetylglucosaminyltransferase V gene, 10.1084/jem.183.3.1173
  12. Gaugler Béatrice, Brouwenstijn Nathalie, Vantomme Valérie, Szikora Jean-Pierre, der Spek C. W. Van, Patard Jean-Jacques, Boon Thierry, Schrier Peter, den Eynde Benoît J. Van, A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma, 10.1007/s002510050133
  13. Coulie P. G., Lehmann F., Lethe B., Herman J., Lurquin C., Andrawiss M., Boon T., A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma., 10.1073/pnas.92.17.7976
  14. Lupetti Raffaella, Pisarra Patrizia, Verrecchia Alessandro, Farina Cinthia, Nicolini Gabriella, Anichini Andrea, Bordignon Claudio, Sensi Marialuisa, Parmiani Giorgio, Traversari Catia, Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage, 10.1084/jem.188.6.1005
  15. Robbins, J. Immunol., 159, 303 (1997)
  16. Wang, J. Immunol., 161, 3596 (1998)
  17. Wang R. F., Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen, 10.1084/jem.183.3.1131
  18. Aarnoudse Corlien A., van den Doel Petra B., Heemskerk Bianca, Schrier Peter I., Interleukin-2-induced, melanoma-specific T cells recognize camel, an unexpected translation product ofLAGE-1, 10.1002/(sici)1097-0215(19990730)82:3<442::aid-ijc19>3.0.co;2-z
  19. Skipper J. C., An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins, 10.1084/jem.183.2.527
  20. Brandle D., A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma, 10.1084/jem.183.6.2501
  21. Gaudin, J. Immunol., 162, 1730 (1999)
  22. Bernhard Helga, Karbach Julia, Wölfel Thomas, Busch Petra, Störkel Stefan, Stöckle Michael, Wölfel Catherine, Seliger Barbara, Huber Christoph, Zum Büschenfelde Karl-Hermann Meyer, Knuth Alexander, Cellular immune response to human renal-cell carcinomas: Definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-Lymphocyte (CTL) clones, 10.1002/ijc.2910590621
  23. Brouwenstijn Nathalie, Hoogstraten Connie, Verdegaal Els M. E., Van der Spek Corry W., Deckers Joan G., Mulder Arend, Osanto Susanne, Schrier Peter I., Definition of Unique and Shared T-Cell Defined Tumor Antigens in Human Renal Cell Carcinoma : , 10.1097/00002371-199811000-00004
  24. Gazdar, Cancer Res., 46, 6011 (1986)
  25. Detrisac Carol J., Sens Mary Ann, Garvin A. Julian, Spicer Samuel S., Sens Donald A., Tissue culture of human kidney epithelial cells of proximal tubule origin, 10.1038/ki.1984.28
  26. Deen Peter MT, van Os Carel H, Epithelial aquaporins, 10.1016/s0955-0674(98)80055-0
Bibliographic reference Van den Eynde, Benoît ; Gaugler, Béatrice ; Probst-Kepper, Michael ; Michaux, Lucienne ; Devuyst, Olivier ; et. al. A new antigen recognized by cytolytic T lymphocytes on a human kidney tumor results from reverse strand transcription. In: The Journal of Experimental Medicine, Vol. 190, no. 12, p. 1793-1800 (1999)
Permanent URL http://hdl.handle.net/2078.1/22637